Rome: While multiple research groups are developing potential vaccines, Italian scientists have claimed to develop a vaccine that has successfully generated antibodies in mice that work on human cells. The vaccine has been tested in the Spallanzani Hospital hospital in Rome. It is said to be one of the most advanced stages of testing of a potential vaccine in the country as the vaccine neutralizes the SARS-CoV-2 in the human cells.
After a single vaccination, the mice developed antibodies that can block the virus from infecting human cells. The researchers selected the two best candidates after observing that the five vaccine candidates generated a large number of antibodies.
speeds never before seen.
Fueling expectations
But mounting promises that some vaccine may be available for emergency use within a few months are fueling expectations that are simply unrealistic, experts warn.
Even if the stages of vaccine development could be compressed and supplies could be rapidly manufactured and deployed, it could take many more months or longer before most Americans would be able to roll up their sleeves. And in many countries around the world, the wait could be far longer still — perpetuating the worldwide risk the new coronavirus poses for several years to come.
That reality is being obscured by reports that some of the earliest vaccine candidates — including one from the biotechnology company Moderna and another from University of Oxford — may within months have enough evidence behind them to be administered on an emergency use basis.
